Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chuanyu Sun

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
Urologic Oncology|December 24, 2013
Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBCWeihong Ding, Yuancheng Gou, Chuanyu Sun, et al.
BMC Proceedings|March 1, 2012
Evaluation of association tests for rare variants using simulated data sets in the Genetic Analysis Workshop 17 dataWenan Chen, Xi Gao, Jiexun Wang, et al.
Cancer Epidemiology|March 18, 2014
Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?Weihong Ding, Zhongqing Chen, Yuancheng Gou, et al.
Cancer Cell International|December 9, 2020
Characterization and validation of long noncoding RNAs as new candidates in prostate cancerShengyang Ge, Yuanyuan Mi, Xiaojun Zhao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2022
Coexistence of tet(A) and bla<sub>KPC-2</sub> in the ST11 hypervirulent tigecycline- and carbapenem-resistant Klebsiella pneumoniae isolated from a blood sampleXiaokui Zhu, Changwu Yue, Huaixin Geng, et al.
Journal of Translational Medicine|July 1, 2011
Periostin: a promising target of therapeutical intervention for prostate cancerChuanyu Sun, Xiaojun Zhao, Ke Xu, et al.
Biochemical and Biophysical Research Communications|November 14, 2017
Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cellsYuanyuan Mi, Chuanyu Sun, Bingbing Wei, et al.
Urology|February 12, 2011
Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason scoreWeiwei Liu, Jian Gong, Jinghui Hu, et al.
Proteome Science|April 21, 2011
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsyChuanyu Sun, Chao Song, Zhicheng Ma, et al.
World Journal of Urology|April 21, 2015
Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groupsWeihong Ding, Shijun Tong, Yuancheng Gou, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Urologic Oncology|December 24, 2013
Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBCWeihong Ding, Yuancheng Gou, Chuanyu Sun, et al.
BMC Proceedings|March 1, 2012
Evaluation of association tests for rare variants using simulated data sets in the Genetic Analysis Workshop 17 dataWenan Chen, Xi Gao, Jiexun Wang, et al.
Cancer Epidemiology|March 18, 2014
Are EORTC risk tables suitable for Chinese patients with non-muscle-invasive bladder cancer?Weihong Ding, Zhongqing Chen, Yuancheng Gou, et al.
Cancer Cell International|December 9, 2020
Characterization and validation of long noncoding RNAs as new candidates in prostate cancerShengyang Ge, Yuanyuan Mi, Xiaojun Zhao, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 2, 2022
Coexistence of tet(A) and bla<sub>KPC-2</sub> in the ST11 hypervirulent tigecycline- and carbapenem-resistant Klebsiella pneumoniae isolated from a blood sampleXiaokui Zhu, Changwu Yue, Huaixin Geng, et al.
Journal of Translational Medicine|July 1, 2011
Periostin: a promising target of therapeutical intervention for prostate cancerChuanyu Sun, Xiaojun Zhao, Ke Xu, et al.
Biochemical and Biophysical Research Communications|November 14, 2017
Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cellsYuanyuan Mi, Chuanyu Sun, Bingbing Wei, et al.
Urology|February 12, 2011
Quantitative assessment of AKAP12 promoter methylation in human prostate cancer using methylation-sensitive high-resolution melting: correlation with Gleason scoreWeiwei Liu, Jian Gong, Jinghui Hu, et al.
Proteome Science|April 21, 2011
Periostin identified as a potential biomarker of prostate cancer by iTRAQ-proteomics analysis of prostate biopsyChuanyu Sun, Chao Song, Zhicheng Ma, et al.
World Journal of Urology|April 21, 2015
Human epidermal growth factor receptor 2: a significant indicator for predicting progression in non-muscle-invasive bladder cancer especially in high-risk groupsWeihong Ding, Shijun Tong, Yuancheng Gou, et al.
Pageof 8